Home Compare GILD vs MRK
Stock Comparison · Industry comparison · Drug Manufacturers - General

Gilead Sciences vs Merck & Co.: Which Stock Looks Stronger in 2026?

Gilead Sciences holds the cleaner structural position, with the lead spread across profitability and growth. The remaining gap is narrow enough that the comparison remains open to different readings. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The lead is spread across profitability and growth, rather than sitting in one isolated gap.

INDUSTRY COMPARISON

Both operate in: Drug Manufacturers - General

This comparison is based on industry proximity, not on functional trajectory similarity. GILD and MRK share the same industry classification.

For a similarity-based comparison, see how Gilead Sciences and Merck each position within their functional peer groups in AssetNext.

Peer-Relative Score
GILD
Gilead Sciences, Inc.
70
Peer-Score
Signal qualityHigh
vs
MRK
Merck & Co., Inc.
63
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: GILD vs MRK Profitability 79 62 Stability 65 57 Valuation 83 88 Growth 44 31 GILD MRK
Gap Ranking
#1 Profitability +17
#2 Growth +13
#3 Stability +8
#4 Valuation +5
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for GILD and MRK Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer GILDMRK Relative valuation Structural strength

The setup is mixed: neither company clearly combines the stronger profile with the more supportive price setup.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
Both rank well on profitability, but Gilead Sciences, Inc. still sits higher.
Growth
Growth also leans toward Gilead Sciences, Inc., reinforcing the broader structural lead.
Profitability — Dominant Gap
GILD
79
MRK
62
Gap+17in favour of GILD

The clearest distance comes from a stronger profitability profile.

What else supports the lead

Earnings growth is one contributing factor within the growth lead.

What this means for the comparison

The lead is built on both profitability and growth, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the GILD vs MRK comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar profitability-and-growth comparisons

Explore how GILD and MRK each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.